Risk of hepatitis B reactivation in rheumatic patients receiving tocilizumab treatment. Annals of Medical Research, [S. l.], v. 32, n. 11, p. 512–517, 2025. Disponível em: http://www.annalsmedres.org/index.php/aomr/article/view/4880. Acesso em: 2 dec. 2025.